JP3203572B2 - Method for improving palatability of pine extract and oral intake obtained by this method - Google Patents
Method for improving palatability of pine extract and oral intake obtained by this methodInfo
- Publication number
- JP3203572B2 JP3203572B2 JP11204793A JP11204793A JP3203572B2 JP 3203572 B2 JP3203572 B2 JP 3203572B2 JP 11204793 A JP11204793 A JP 11204793A JP 11204793 A JP11204793 A JP 11204793A JP 3203572 B2 JP3203572 B2 JP 3203572B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- pine
- pine extract
- weight
- palatability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000284 extract Substances 0.000 title claims description 161
- 241000018646 Pinus brutia Species 0.000 title claims description 104
- 235000008331 Pinus X rigitaeda Nutrition 0.000 title claims description 103
- 235000011613 Pinus brutia Nutrition 0.000 title claims description 103
- 238000000034 method Methods 0.000 title claims description 30
- 235000019629 palatability Nutrition 0.000 title claims description 24
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 31
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 31
- 241001330002 Bambuseae Species 0.000 claims description 31
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 31
- 239000011425 bamboo Substances 0.000 claims description 31
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims description 20
- 230000037406 food intake Effects 0.000 claims description 20
- 239000007787 solid Substances 0.000 claims description 20
- 201000010099 disease Diseases 0.000 claims description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 235000013402 health food Nutrition 0.000 claims description 3
- 229960005475 antiinfective agent Drugs 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 description 25
- 239000000047 product Substances 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 230000001737 promoting effect Effects 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 14
- 238000011084 recovery Methods 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 10
- 241000700605 Viruses Species 0.000 description 9
- 235000013361 beverage Nutrition 0.000 description 9
- 230000036541 health Effects 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 210000002540 macrophage Anatomy 0.000 description 8
- 239000000419 plant extract Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 208000007107 Stomach Ulcer Diseases 0.000 description 7
- 235000019606 astringent taste Nutrition 0.000 description 7
- 201000005917 gastric ulcer Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 6
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 6
- 235000005493 rutin Nutrition 0.000 description 6
- 229960004555 rutoside Drugs 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 235000021110 pickles Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 239000004278 EU approved seasoning Substances 0.000 description 3
- 239000002211 L-ascorbic acid Substances 0.000 description 3
- 235000000069 L-ascorbic acid Nutrition 0.000 description 3
- 244000018795 Prunus mume Species 0.000 description 3
- 235000011158 Prunus mume Nutrition 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 235000015243 ice cream Nutrition 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 description 2
- YBHQCJILTOVLHD-YVMONPNESA-N Mirin Chemical compound S1C(N)=NC(=O)\C1=C\C1=CC=C(O)C=C1 YBHQCJILTOVLHD-YVMONPNESA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 235000000405 Pinus densiflora Nutrition 0.000 description 2
- 240000008670 Pinus densiflora Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 241000711975 Vesicular stomatitis virus Species 0.000 description 2
- -1 acidulants Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000013622 meat product Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 239000013588 oral product Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 235000015067 sauces Nutrition 0.000 description 2
- 235000013580 sausages Nutrition 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000021419 vinegar Nutrition 0.000 description 2
- 239000000052 vinegar Substances 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241001137251 Corvidae Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000257465 Echinoidea Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241000218641 Pinaceae Species 0.000 description 1
- 240000007263 Pinus koraiensis Species 0.000 description 1
- 235000011615 Pinus koraiensis Nutrition 0.000 description 1
- 241000018650 Pinus massoniana Species 0.000 description 1
- 235000011610 Pinus tabuliformis Nutrition 0.000 description 1
- 235000008585 Pinus thunbergii Nutrition 0.000 description 1
- 241000218686 Pinus thunbergii Species 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241001441723 Takifugu Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 235000020057 cognac Nutrition 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000020186 condensed milk Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 235000021549 curry roux Nutrition 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 235000020094 liqueur Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000015108 pies Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000012773 waffles Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は、マツエキスの嗜好性改
善方法およびこの方法により得られるマツエキス含有経
口摂取物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for improving palatability of pine extract and a pine extract-containing oral ingestible product obtained by the method.
【0002】[0002]
【従来の技術】マツエキスは、各種のマツ、例えば、ア
カマツ、クロマツ、ゴヨウマツ、シナマツ、チョウセン
マツなどの葉、枝、実、マツカサなどを水、またはアル
コールなどにより抽出して調製され、これには、精油、
フラボノイドなどが含まれてお、古くから民間療法薬と
して経口摂取により利用されてきた。2. Description of the Related Art Pine extract is prepared by extracting leaves, branches, nuts, pine pine, etc. of various types of pine, such as Japanese red pine, Japanese black pine, Japanese pine, Chinese pine, Korean pine, etc., with water or alcohol. , Essential oils,
It contains flavonoids and has been used orally as a folk remedy since ancient times.
【0003】その主な薬理作用は、血液の循環をよく
し、心臓、肝臓、腎臓などの機能を向上し、高血圧や心
筋梗塞を予防し、食欲増進、疲労の回復促進、免疫増
強、感染予防などである。[0003] Its main pharmacological actions are to improve blood circulation, improve the functions of the heart, liver and kidneys, prevent hypertension and myocardial infarction, increase appetite, promote recovery from fatigue, enhance immunity, and prevent infection. And so on.
【0004】しかしながら、マツエキスは、激しいマツ
ヤニ臭があり、加えて強い苦味、渋味も有しており、経
口摂取する上で大きな欠点になっている。[0004] However, the pine extract has an intense pine odor and also has a strong bitterness and astringency, which is a major drawback when taken orally.
【0005】これを緩和する方法として、例えば、特公
昭42−3821号公報、特開昭54−41369号公
報、特開昭61−282059号公報、特開昭61−2
89865号公報、特開平1−300880号公報など
に提案されている発酵方法がある。これら発酵方法につ
いて鋭意検討を続けてきたところ、次の欠点のあること
が判明した。As a method for alleviating this, for example, Japanese Patent Publication No. 42-3821, Japanese Patent Application Laid-Open No. 54-41369, Japanese Patent Application Laid-Open No. 61-282059, and Japanese Patent Application
There are fermentation methods proposed in JP 89865, JP-A-1-300880, and the like. As a result of intensive studies on these fermentation methods, the following disadvantages were found.
【0006】(1)マツヤニ臭や苦味、渋味などが一部
緩和されるものの、その効果は、なお不充分である。(1) Although some of the odor, bitterness, astringency and the like of Matsutani are alleviated, the effect is still insufficient.
【0007】(2)発酵中に、マツエキスの有効成分を
変質、劣化、損失することとなり、マツエキス本来の効
能、効果が低減する。(2) During fermentation, the active ingredients of the pine extract are altered, deteriorated, or lost, and the original efficacy and effect of the pine extract are reduced.
【0008】(3)発酵終了液を濾過精製する工程で、
マツエキスの有効成分が、菌体などに吸着、除去され、
その収量が低減する。(3) In the step of filtering and purifying the fermentation-finished liquid,
The active ingredient of the pine extract is adsorbed and removed from the cells,
The yield is reduced.
【0009】このため一般的には、マツエキスは、甘味
料で甘味付けする程度で、マツヤニ臭や苦味、渋昧など
を残したまま、これをがまんして利用しているのが現状
である。[0009] For this reason, the pine extract is generally used only to the extent that it is sweetened with a sweetener while retaining the pine odor, bitterness, astringency and the like.
【0010】[0010]
【発明が解決しようとする課題】前記欠点を解消し、嗜
好性が優れ、しかも効能、効果を高めたマツエキス含有
経口摂取物の確立が強く望まれている。SUMMARY OF THE INVENTION There is a strong demand for establishment of a pine extract-containing oral ingestion which overcomes the above-mentioned disadvantages, has excellent palatability, and has enhanced efficacy and effect.
【0011】[0011]
【課題を解決するための手段】本発明は、前記欠点を解
消するためになされたものである。SUMMARY OF THE INVENTION The present invention has been made to solve the above-mentioned drawbacks.
【0012】本発明者等は、マツエキスの嗜好性を改善
し、その効果、効能を高めたマツエキス含有経口摂取物
の確立を目ざし、民間療法薬として用いられている各種
植物エキスを配合することに着目して鋭意研究を続けて
きた。The present inventors aimed at establishing a pine extract-containing oral ingestion which improved the palatability of pine extract, and improved its effect and efficacy, by blending various plant extracts used as folk remedies. We have been focusing our research on this.
【0013】その結果、意外にも、、マツエキスと、そ
れ自体では激しいワラ臭、強い苦味、渋味を有するタケ
エキスおよび激しいコゲ臭、強い苦味、渋味、酸味を有
するウメエキスとの特定割合での併用が本目的に合致す
ることを見いだし、本発明を完成した。As a result, surprisingly, a certain ratio of the pine extract to the bamboo extract which itself has a strong straw odor, strong bitterness and astringency, and a plum extract which has a strong kogane odor, strong bitterness, astringency and sourness are obtained. The present inventors have found that the combination is suitable for the purpose and completed the present invention.
【0014】すなわち、マツエキスに対して、タケエキ
スおよびウメエキスを固形物当り、それぞれ0.1乃至
20倍量および1乃至200倍量含有せしめたマツエキ
ス含有経口摂取物は、マツエキスの嗜好性を著しく向上
させ、その上、マツエキスの効能、効果を増強しうるこ
とを見いだし、本発明を完成した。That is, the pine extract-containing oral ingestion containing 0.1 to 20 times and 1 to 200 times the bamboo extract and the plum extract, respectively, of the pine extract, based on the solid matter, significantly improves the palatability of the pine extract. In addition, they have found that the efficacy and effect of the pine extract can be enhanced and completed the present invention.
【0015】更に、これらタケエキス、ウメエキスに加
えて、水溶性のα−グリコシル ルチンの併用は、本発
明のマツエキス含有経口摂取物の品質、効能、効果を一
段と高めることを見いだし、本発明を完成した。Furthermore, it has been found that the combined use of a water-soluble α-glycosyl rutin in addition to the bamboo extract and the plum extract further enhances the quality, efficacy and effect of the pine extract-containing oral ingestion of the present invention, and has completed the present invention. .
【0016】本発明に用いるマツエキスは、マツ科植物
の葉、枝、実、マツカサ、樹皮、組織培養物などから抽
出されるエキスであって、その抽出方法は限定されず、
公知の方法を適宜採用すればよい。The pine extract used in the present invention is an extract extracted from leaves, branches, nuts, pine moss, bark, tissue culture and the like of Pinaceae plants, and the extraction method is not limited.
A known method may be appropriately adopted.
【0017】通常は、例えば、特開昭63−21060
号公報に開示されている水やエタノールなどの親水性有
機溶媒による方法、また、例えば、特開平1−2385
32号公報に開示されているアルカリ水による方法など
が採用される。Usually, for example, Japanese Patent Application Laid-Open No. 63-21060
JP-A-1-2385 discloses a method using a hydrophilic organic solvent such as water or ethanol disclosed in
No. 32, a method using alkaline water or the like is adopted.
【0018】必要ならば、例えば、特開昭62−172
096号公報に開示されている二酸化炭素の超臨界状態
の流体による方法を採用してもよい。If necessary, see, for example, JP-A-62-172.
No. 096, a method using a fluid in a supercritical state of carbon dioxide may be employed.
【0019】このようにして得られるエキスは、液状、
ペースト状または粉末状であり、その形状は、目的に応
じて適宜選択できる。必要に応じて、市販の松葉エキス
を用いることも有利に実施できる。The extract thus obtained is liquid,
It is in the form of a paste or powder, and the shape can be appropriately selected according to the purpose. If necessary, a commercially available pine needle extract can be advantageously used.
【0020】本発明に用いるタケエキスは、タケ、ササ
類植物の葉、枝、根などから抽出されるエキスであっ
て、その抽出方法は限定されず、マツエキスの場合と同
様に公知の方法が適宜採用できる。必要に応じて、市販
の笹エキス、例えば、隈笹熱水抽出濃縮物などを用いる
ことも有利に実施できる。The bamboo extract used in the present invention, bamboo, bamboo leaf crop plant, branches, a extract which is extracted like from the roots, the extraction method is not limited, a known method as in the case of pine It can be adopted as appropriate. If necessary, a commercially available bamboo extract, for example, a Kumasa hot water extract concentrate can be advantageously used.
【0021】本発明に用いるウメエキスは、ウメの果肉
から調製されるエキスであって、その調製方法は限定さ
れず、公知の方法が適宜採用できる。必要に応じて、市
販の梅肉エキス、例えば、梅エキス食品などを用いるこ
とも有利に実施できる。The plum extract used in the present invention is an extract prepared from plum pulp, and its preparation method is not limited, and a known method can be appropriately employed. If necessary, a commercially available plum extract, for example, a plum extract food can be advantageously used.
【0022】本発明に用いるα−グリコシル ルチン
は、ルチンにD−グルコースが等モル以上α−結合した
もので、水溶性に優れ、経口摂取されると、生体内でル
チンとD−グルコースとに分解され、ルチン本来の生理
効果を発揮する。The α-glycosyl rutin used in the present invention is rutin in which D-glucose is α-bonded in equimolar or more, has excellent water solubility, and when taken orally, converts rutin and D-glucose in vivo. It is decomposed and exhibits rutin's original physiological effect.
【0023】α−グリコシル ルチンの調製方法は、特
開平3−58790号公報、特開平3−115292号
公報などに開示されている糖転移酵素による反応方法を
採用すればよい。必要に応じて、市販のα−グリコシル
ルチンを用いることも有利に実施できる。As a method for preparing α-glycosyl rutin, a reaction method using a glycosyltransferase disclosed in JP-A-3-58790 and JP-A-3-115292 may be employed. If necessary, commercially available α-glycosyl rutin can be advantageously used.
【0024】なお、このα−グリコシル ルチンが養毛
剤として使用できることは、特開平4−46112号公
報に開示されている。The use of this α-glycosyl rutin as a hair restorer is disclosed in JP-A-4-46112.
【0025】本発明のマツエキス含有経口摂取物は、本
発明の目的が達成できるものであればよく、その形態と
しては、時間に追われているビジネスマンのような人も
手軽に摂取しうる、例えば、ドリンク剤、顆粒、錠剤な
とが好適である。The pine extract-containing oral ingestion of the present invention may be any as long as the object of the present invention can be achieved, and it can be easily ingested by a person such as a business man who is busy with time. For example, drinks, granules, and tablets are suitable.
【0026】本発明のマツエキス含有経口摂取物は、マ
ツエキスはもとより、タケエキス、ウメエキスを、更に
は、必要に応じて、α−グリコル ルチンを所定量含有
せしめたものであればよい。その量としては、マツエキ
スを固形物当り0.01w/w%(以下、特にことわら
ない限り、本明細書ではw/w%を%で示す。)以上、
望ましくは、0.02乃至5%の範囲に含有せしめるの
が好適である。0.01%未満では、通常の経口摂取量
からしてマツエキスの効能、効果が期待できず、また、
5%を越えては、タケエキス、ウメエキスによる嗜好性
の改善が不充分になる。The pine extract-containing oral ingestion of the present invention may be any pine extract, bamboo extract, plum extract and, if necessary, α-glycolrutin in a predetermined amount. The amount of the pine extract is 0.01 w / w% per solid (hereinafter, unless otherwise specified, w / w% is indicated by% in this specification).
Desirably, the content is preferably in the range of 0.02 to 5%. If it is less than 0.01%, the efficacy and effect of the pine extract cannot be expected from the usual oral intake,
If it exceeds 5%, the improvement of palatability by bamboo extract and plum extract becomes insufficient.
【0027】また、マツエキスに対するタケエキスおよ
びウメエキスの量は、固形物当り、それぞれ0.1乃至
20倍量、望ましくは、0.5乃至10倍量および1乃
至200倍量、望ましくは5乃至100倍量の範囲が好
適である。この量は、マツエキスの嗜好性を向上する上
で好適であるばかりでなくマツエキスの効能、効果を増
強する点からも好都合である。The amount of bamboo extract and ume extract relative to the pine extract is 0.1 to 20 times, preferably 0.5 to 10 times and 1 to 200 times, preferably 5 to 100 times, based on the solid matter. A range of amounts is preferred. This amount is suitable not only for improving the palatability of the pine extract, but also for enhancing the efficacy and effect of the pine extract.
【0028】また、マツエキスに対するα−グリコシル
ルチンの量は、固形物当り、0.1乃至10倍量の範
囲が経口摂取物の効能、効果を増強する上で、また保存
安定性を高める上で、更には、養毛効果を高める上で好
適である。The amount of α-glycosyl rutin relative to the pine extract is in the range of 0.1 to 10 times the amount per solid, in order to enhance the efficacy and effect of the oral ingestion and to enhance the storage stability. Further, it is suitable for enhancing the hair-growing effect.
【0029】以上述べた特定割合で含有せしめれば、通
常、pH約2乃至4.5の範囲に入るが、もし、これを
はずれるようであれば、嗜好性の点から、適宜のpH調
整剤により、このpH範囲に整えるのが望ましい。[0029] If contained in the above-mentioned specific ratio, the pH usually falls in the range of about 2 to 4.5, but if it is out of this range, from the viewpoint of palatability, an appropriate pH adjuster is used. It is desirable to adjust the pH to this range.
【0030】ただし、本発明でいうpHは、pHメータ
ーにて測定する値であり、経口摂取物が水溶液の場合は
そのままで測定し、固形物の場合は、濃度10%程度の
水溶液にして測定する。However, the pH referred to in the present invention is a value measured with a pH meter. When the oral ingestion is an aqueous solution, it is measured as it is, and when it is a solid, it is measured as an aqueous solution having a concentration of about 10%. I do.
【0D31】また、今まで述べてきた成分以外に、必要
に応じて適宜の添加物、例えば、着香料、着色料、酸味
料、甘味料、ビタミン、ミネラル、動植物エキス、生理
活性物質、増量剤、臓形剤などの一種または二種以上を
併用して本発明のマツエキス含有経口摂取物の嗜好性を
更に向上させることも、健康の維持、増進、各種疾患の
予防、治療、回復促進を更に増強することも有利に実施
できる。In addition to the components described so far, if necessary, appropriate additives such as flavoring agents, coloring agents, acidulants, sweeteners, vitamins, minerals, animal and plant extracts, physiologically active substances, and bulking agents Further, it is possible to further improve the palatability of the pine extract-containing oral ingestion of the present invention by using one or two or more of visceral preparations, etc., and also to maintain, promote health, prevent, treat, and promote recovery of various diseases. Augmentation can also be advantageously implemented.
【0032】本発明のマツエキス含有経口摂取物に含有
せしめる方法としては、製品が完成するまでの工程で、
例えば、混和、混捏、溶解、浸漬、散布、注入など公知
の配合方法が適宜選ばれる。The method of incorporating the pine extract-containing oral ingestion of the present invention into
For example, a known compounding method such as mixing, kneading, dissolving, dipping, spraying, and pouring is appropriately selected.
【0033】このようにして得られる本発明のマツエキ
ス含有経口摂取物は、その嗜好性が向上しているだけで
なく、先に述べたマツエキスの持つ薬理作用に加えて、
タケエキスの持つ殺菌、口臭の除去、消炎、血圧降下、
鎖静、抗腫瘍、免疫賦活などの作用、更には、ウメエキ
スの持つ整腸、食欲増進、疲労回復、血液浄化、体質改
善などの作用が相乗的に加わることとなり、健康飲食物
としては勿論のこと、養毛剤、抗感受性疾患剤としても
有利に用いられる。The thus-obtained pine extract-containing oral ingestion of the present invention not only has improved palatability but also has the above-mentioned pharmacological action of the pine extract,
Sterilization of bamboo extract, removal of bad breath, anti-inflammatory, blood pressure lowering,
Actions such as chain static, anti-tumor, immunostimulation, etc., and the actions of plum extract such as intestinal control, appetite enhancement, recovery from fatigue, blood purification, constitution improvement etc. will be added synergistically, and of course, as a healthy food and drink It is also advantageously used as a hair restorer and an anti-sensitive disease agent.
【0034】抗感受性疾患剤とは、感受性疾患のための
予防剤、治療剤を意味し、感受性疾患とは、本発明のマ
ツエキス含有経口摂取物によって予防され、若しくは治
療される疾患を意味する。感受性疾患としては、例え
ば、ウイルス、細菌などによる感染性疾患、高血圧、心
筋梗塞など循環器疾患、ストレス症候群など神経疾患、
免疫疾患、悪性腫瘍などがある。[0034] The antisensitizing agent means a prophylactic or therapeutic agent for a susceptible disease, and the susceptible disease means a disease which is prevented or treated by the pine extract-containing oral ingestion of the present invention. Examples of susceptible diseases include infectious diseases caused by viruses and bacteria, hypertension, cardiovascular diseases such as myocardial infarction, neurological diseases such as stress syndrome,
There are immune diseases and malignant tumors.
【0035】投与量は、含量、摂取頻度などによって適
宜調節することができる。通常、マツエキス固形物とし
て、成人一日当り約0.001乃至10グラムの範囲の
利用が好適である。The dose can be appropriately adjusted depending on the content, the frequency of intake, and the like. In general, it is preferable to use pine extract solids in the range of about 0.001 to 10 grams per adult per day.
【0036】また、本発明のマツエキス含有経口摂取物
は、塩から味、渋味、旨味などを呈する各種物質ともよ
く調和し、静菌作用、抗酸化作用も強いので、特定分野
の健康飲食物、抗感受性疾患剤に限られることなく、広
く一般の飲食物、嗜好物、例えば、醤油、フリカケ、マ
ヨネーズ、ドレッシング、三杯酢、中華の素、天つゆ、
麺つゆ、ソース、ケチャップ、焼肉のタレ、カレール
ウ、シチューの素、スープの素、ダシの素、複合調味
料、新みりんなどの各種調味料、おこし、カリントウ、
求肥、餅類、まんじゅう、ういろう、あん類、羊かん、
水羊かん、錦玉、ゼリー、カステラ、飴玉などの各種和
菓子、パン、クッキー、パイ、プリン、シュークリー
ム、ワッフル、スポンジケーキ、ドーナツ、チョコレー
ト、チューインガム、キャラメル、キャンデーなどの各
種洋菓子、アイスクリーム、シャーベットなどの氷菓、
果実のシロップ漬、氷蜜などのシロップ類、福神漬、千
枚漬、らっきょう漬などの漬物類、ハム、ソーセージな
どの畜肉製品類、魚肉ハム、魚肉ソーセージ、カマボ
コ、チクワ、ハンペンなどの魚肉製品、ウニ、イカの塩
辛、酢コンブ、さきするめ、ふぐのみりん干しなどの各
種珍味類、果実酒、洋酒などの酒類、コーヒー、ココ
ア、ジュース、炭酸飲料、乳酸飲料、乳酸菌飲料などの
清涼飲料水などに配合して、それらの風味改善、日持向
上、品質安定などの目的で有利に利用できる。The pine extract-containing oral ingestion of the present invention is well harmonized with various substances exhibiting taste, astringency, umami and the like from salt, and has a strong bacteriostatic and antioxidant action. , Not limited to anti-susceptibility agents, widely used foods and drinks, foods, such as soy sauce, frikake, mayonnaise, dressing, three tablespoon vinegar, Chinese ingredients, Tentsuyu,
Various seasonings such as noodle soup, sauce, ketchup, grilled meat sauce, curry roux, stew ingredients, soup ingredients, dashi ingredients, complex seasonings, new mirin, rice, kalinto,
Fertilizer, rice cakes, steamed buns, seaweed, bean jam, sheep,
Various Japanese sweets such as Mizuhyokan, Nishiki, jelly, castella, candy, bread, cookies, pies, pudding, cream puffs, waffles, sponge cakes, donuts, chocolate, chewing gum, caramel, candy and other Western confections, ice cream, sherbet Such as ice confections,
Syrups such as fruit syrup pickles, ice honey, etc., pickles such as Fukujin pickles, senmai pickles, lucky pickles, meat products such as ham, sausage, fish meat ham, fish sausage, fish meat products such as kamaboko, chikuwa, hampen, sea urchins, Formulated in various delicacies such as salted squid, vinegar comb, Sakisume, dried fugu mirin, liquors such as fruit wine and Western liquor, coffee, cocoa, juice, carbonated drinks, lactic acid drinks, lactic acid drinks and other soft drinks Then, it can be advantageously used for the purpose of improving the flavor, improving the shelf life, and stabilizing the quality.
【0037】更に、家畜、家禽、蜜蜂、蚕、魚など飼育
動物のための飼料、餌料などに抗菌剤、整腸剤、ストレ
ス解消剤、嗜好性向上などの目的で配合して利用するこ
とも好都合である。Further, it is also convenient to use it in a feed, feed, or the like for livestock, poultry, bees, silkworms, fish, or other breeding animals for the purpose of, for example, an antibacterial agent, an intestinal regulator, a stress relieving agent, or improving palatability. is there.
【0038】その他、タバコ、トローチ、舌下剤、口中
香錠、口中清涼剤、うがい薬、練歯みがき、チューイン
ガムなどの化粧品分野での口中使用物などとしても有利
に利用できる。In addition, it can be advantageously used as a to-be-used product in the field of cosmetics such as tobacco, troches, sublinguals, mouthwashes, mouthwash, mouthwash, toothpaste and chewing gum.
【0039】以下、実験で本発明を詳細に説明する。Hereinafter, the present invention will be described in detail by experiments.
【0040】[0040]
【実験1】 マツエキスの嗜好性に与える各種植物エキスの影響[Experiment 1] Effect of various plant extracts on the taste of pine extract
【0041】マツエキスの臭気と嫌味を改善する目的
で、マツエキスと民間療法薬として広く用いられている
各種植物エキスとを配合し、その嗜好性をパネルテスト
により評価した。For the purpose of improving the odor and unpleasant taste of the pine extract, the pine extract was blended with various plant extracts widely used as folk remedies, and their palatability was evaluated by a panel test.
【0042】マツエキスは、常法によりマツ葉から調製
し、その濃度を0.1w/v%とした。他の植物エキス
は、市販品、または常法により調製し、その濃度を1.
0w/v%とした。マツエキスとその他の各種植物エキ
スのそれぞれを同容量ずつ混合した。対照として、マツ
エキスに同容量の水を混合した。また、甘味料として砂
糖を5w/v%になるよう溶解した。The pine extract was prepared from pine leaves by a conventional method, and the concentration was adjusted to 0.1 w / v%. Other plant extracts are commercially available or prepared by a conventional method, and the concentration thereof is set to 1.
0 w / v%. Pine extract and various other plant extracts were mixed in equal volumes. As a control, the same volume of water was mixed with the pine extract. In addition, sugar was dissolved as a sweetener so as to be 5 w / v%.
【0043】したがって、パネルテストに供した試料の
基本配合は、マツエキス0.05w/v%、その他の植
物エキス0.5w/v%、砂糖5w/v%である。パネ
ラーは、16名で、男性10名、女性6名の構成であ
り、24℃でパネルテストを行った。Therefore, the basic composition of the samples subjected to the panel test is pine extract 0.05 w / v%, other plant extracts 0.5 w / v%, and sugar 5 w / v%. The panelists consisted of 16 persons, 10 men and 6 women, and conducted a panel test at 24 ° C.
【0044】結果は表1に示す。The results are shown in Table 1.
【0045】[0045]
【表1】 [Table 1]
【0046】なお、評価において、0点は、臭気、嫌味
が強すぎて経口摂取するのがつらい。1点は、臭気、嫌
味があるものの経口摂取は充分可能である。2点は、嗜
好性に優れ、経口摂取が容易である、とした。In the evaluation, a score of 0 indicates that the odor and the unpleasant taste are too strong to be taken orally. One is that although it has an odor and a bad taste, it can be taken orally. The two points were that the palatability was excellent and oral ingestion was easy.
【0047】表1の結果から明らかなように、マツエキ
スに、各種植物エキスを併用したところ、タケエキスと
ウメエキスそれぞれに著しい嗜好性の改善作用が見いだ
された。As is clear from the results shown in Table 1, when various plant extracts were used in combination with the pine extract, a remarkable palatability-improving action was found for each of the bamboo extract and the plum extract.
【0048】[0048]
【実験2】 マツエキスの嗜好性に与えるタケエキス、ウメエキスの
影響[Experiment 2] Effect of bamboo extract and plum extract on the taste of pine extract
【0049】マツエキスとともにタケエキスおよびウメ
エキスを含有せしめて、その嗜好性をパネルテストによ
り評価した。パネルテストに供した試料としては、マツ
エキス0.05w/v%、砂糖5w/v%の場合と、マ
ツエキス0.2w/v%、砂糖10w/v%の場合との
2群を設け、それぞれの場合に、タケエキスおよびウメ
エキスを、マツエキスに対して固形物当り、それぞれ
0.1乃至20倍量および1乃至200倍量を含有せし
めたものを調製した。A bamboo extract and a plum extract were included together with the pine extract, and their palatability was evaluated by a panel test. As samples subjected to the panel test, two groups, a case of pine extract 0.05 w / v% and sugar 5 w / v%, and a case of pine extract 0.2 w / v% and sugar 10 w / v%, were provided. In this case, bamboo extract and plum extract were prepared by adding 0.1 to 20 times and 1 to 200 times the amount of pine extract per solid.
【0050】対照として、タケエキスおよびウメエキス
を含有させないものを調製した。パネルテストは、実験
1の場合と同様に行った。As a control, one containing no bamboo extract and plum extract was prepared. The panel test was performed in the same manner as in Experiment 1.
【0051】結果は表2に示す。The results are shown in Table 2.
【0052】[0052]
【表2】 [Table 2]
【0053】なお、評価基準は、表1の場合と同じにし
た。The evaluation criteria were the same as in Table 1.
【0054】表2の結果から明らかなように、マツエキ
スにタケエキスとウメエキスとを併用したところ、マツ
エキスの嗜好性が著しく改善されることが判明した。そ
の効果は、マツエキス0.05w/v%、0.2w/v
%のいずれの場合においても、タケエキスおよびウメエ
キスを、マツエキスに対して固形物当り、それぞれ約
0.1乃至20倍量および約1乃至200倍量含有せし
めることにより発揮され、とりわけ、0.5乃至10倍
量および5乃至100倍量含有せしめることにより著し
く発揮される。As is clear from the results in Table 2, it was found that when the bamboo extract and the plum extract were used in combination with the pine extract, the palatability of the pine extract was significantly improved. The effect is pine extract 0.05w / v%, 0.2w / v
%, The bamboo extract and the Japanese apricot extract are contained in the pine extract in an amount of about 0.1 to 20 times and about 1 to 200 times, respectively, based on the solid matter. It is remarkably exhibited when the content is 10 times and 5 to 100 times.
【0055】また、これらの供試液にα−グリコシル
ルチン(商品名αG ルチン、東洋精糖株式会社製造)
を、マツエキスに対して、固形物当り0.1倍量または
5倍量含有せしめて同様にパネルテストを行ったとこ
ろ、評価結果は、表2と同じ結果で、α−グリコシル
ルチンがマツエキスの嗜好性に悪影響を与えないことが
判明した。Also, α-glycosyl was added to these test solutions.
Rutin (Product name αG Rutin, manufactured by Toyo Sugar Co., Ltd.)
Was subjected to a panel test in the same manner as in pine extract in an amount of 0.1 times or 5 times the solid content, and the evaluation results were the same as those in Table 2.
It was found that rutin did not adversely affect the palatability of pine extract.
【0056】[0056]
【実験3】 ウイルス抑制効果[Experiment 3] Virus suppression effect
【0057】ウイルス抑制効果は、予め、マツエキス含
有溶液で処理したウイルス(VSV(水泡性口内炎ウイ
ルス)またはHSV−1(単純ヘルペス1型))をFL
細胞に感染させるプラーク半減法により調べた。The virus-suppressing effect was determined by treating a virus (VSV (vesicular stomatitis virus) or HSV-1 (herpes simplex type 1)) previously treated with a pine extract-containing solution in FL.
The cells were examined by plaque halving.
【0058】すなわち、実験2の方法で表2のNo.9
相当品(マツエキス0.2w/v%、砂糖10w/v
%、タケエキス0.5w/v%およびウメエキス5w/
v%を含有する。以降これを「試料A」と呼ぶ。)、お
よび試料Aにα−グリコシルルチンを、マツエキスに対
して固形物当り、等倍量含有せしめたもの(以降これを
「試料B」と呼ぶ。)を調製した。That is, in the method of Experiment 2, No. 9
Equivalent products (pine extract 0.2 w / v%, sugar 10 w / v)
%, Bamboo extract 0.5 w / v% and plum extract 5 w /
v%. Hereinafter, this is referred to as “sample A”. ) And a sample A containing α-glycosylrutin in the same amount as pine extract per solid (hereinafter referred to as “sample B”).
【0059】マツエキスとして表2のNo.7相当品
(以降これを「試料C」と呼ぶ。)を調製した。As a pine extract, No. 7 equivalents (hereinafter referred to as “sample C”) were prepared.
【0060】これらの試料をハンクス(Hanks’)
液(pH7.4)でマツエキスをml当り10または5
0μgになるように希釈してマツエキス含有溶液を調製
した。ウイルス溶液は、濃度をml当り約102乃至1
04プラーク形成単位含有溶液とした。These samples were used in Hanks'
Pine extract in liquid (pH 7.4)
It was diluted to 0 μg to prepare a pine extract-containing solution. Virus solution per ml concentration of about 10 2 to 1
0 4 was plaque forming units-containing solution.
【0061】前記マツエキス含有溶液0.5mlとウイ
ルス溶液0.5mlとを混合し、37℃で1時間処理し
たものを用いてFL細胞に感染させ、形成されるプラー
ク数を測定した。The pine extract-containing solution (0.5 ml) and the virus solution (0.5 ml) were mixed and treated at 37 ° C. for 1 hour to infect FL cells, and the number of plaques formed was measured.
【0062】対照として、マツエキス無含有のウイルス
溶液を調製し、このウイルス溶液で、同様に感染させ、
形成されるプラーク数を測定した。ウイルス抑制率
(%)は、次式により求めた。As a control, a virus solution containing no pine extract was prepared and infected with the virus solution in the same manner.
The number of plaques formed was determined. The virus suppression rate (%) was determined by the following equation.
【0063】[0063]
【式1】 (Equation 1)
【0064】試料A、BおよびCのマツエキス濃度(μ
g/ml)とウイルス抑制率(%)との関係を表3にま
とめた。The pine extract concentrations of samples A, B and C (μ
g / ml) and the virus suppression rate (%) are summarized in Table 3.
【0065】[0065]
【表3】 [Table 3]
【0066】表3の結果から明らかなように、マツエキ
ス自体(試料C)でも、ウイルス抑制効果が見られる
が、その効果は、タケエキスおよびウメエキスの併用
(試料A)により増強される。As is clear from the results in Table 3, the pine extract itself (sample C) also exhibited a virus-suppressing effect, but the effect was enhanced by the combined use of bamboo extract and plum extract (sample A).
【0067】これに、α−グリコシル ルチンの併用
(試料B)によってその効果は、更に増強されることが
判明した。It was also found that the effect was further enhanced by the combined use of α-glycosyl rutin (sample B).
【0068】[0068]
【実験4】 胃潰瘍抑制効果[Experiment 4] Gastric ulcer inhibitory effect
【0069】[0069]
【実験4−1】 ラットへのストレス負荷による胃潰瘍抑制[Experiment 4-1] Inhibition of gastric ulcer by stress load on rats
【0070】ラットへのストレス負荷は、「新薬開発の
ための動物モデル利用集成」(伊藤隆太、高橋良、本田
西男編、第247乃至254頁(1985年)、R&D
プラニング、東京)に於て、松尾等が記載している方法
に準じて、ウイスター系雄ラット、体重280乃至35
0gを金網製ストレスケージに拘束し、水温23℃で1
8時間水浸により、急性胃潰瘍を起こさせた。The stress load on the rat is described in "Utilization of Animal Models for New Drug Development" (edited by Ryuta Ito, Ryo Takahashi, Nishio Honda, pp. 247 to 254 (1985), R & D).
Planning, Tokyo), according to the method described by Matsuo et al., Male Wistar rats, weighing 280-35.
0 g was constrained in a wire mesh stress cage.
Acute gastric ulcer was caused by water immersion for 8 hours.
【0071】[0071]
【実験4−2】 ストレス性胃潰瘍抑制剤の経口投与[Experiment 4-2] Oral administration of stress-induced gastric ulcer inhibitor
【0072】ストレス性胃潰瘍抑制剤として、実験3の
方法で調製した試料A、BおよびCを、それぞれ濃度約
0.3w/v%液に希釈して投与した。対照として、蒸
留水または砂糖を所定濃度に溶解した水溶液を投与し
た。投与方法は、一群8匹とし、一匹当りストレス性胃
潰瘍抑制剤3mlずつをストレス負荷開始10分前に胃
ゾンデを用いて強制的に経口投与した。Samples A, B, and C prepared by the method of Experiment 3 were each administered as a stress gastric ulcer inhibitor after being diluted to a concentration of about 0.3 w / v%. As a control, distilled water or an aqueous solution in which sugar was dissolved at a predetermined concentration was administered. The administration method was 8 animals per group, and 3 ml each of the stress-induced gastric ulcer inhibitor was forcibly administered orally using a gastric tube 10 minutes before the start of stress loading.
【0073】効果の判定は、ストレス負荷後、エーテル
吸入致死せしめて解剖し、胃粘膜上に発生したただれ
(Erosion)の長さ(mm)を測定し、これを合
計してラット一匹当りの潰瘍係数(Ulcer ind
ex)を求めた。The effect was determined by letting the animals be killed by ether inhalation after stress loading, dissecting them, measuring the length (mm) of erosions (Erosion) generated on the gastric mucosa, and summing them up to calculate the per-rat weight. Ulcer index (Ulcer ind
ex).
【0074】結果は表4にまとめた。The results are summarized in Table 4.
【0075】[0075]
【表4】 [Table 4]
【0076】表4の結果から明らかなように、マツエキ
ス(試料C)を投与したV群は、対照のI群(蒸留水投
与群)の潰瘍係数65mmに対して、潰瘍係数が35m
mと約54%に低減しており、また、マツエキスととも
にタケエキスおよびウメエキスを併用したもの(試料
A)を投与したIII群のそれは26mmと約40%に
低減し、更に、α−グリコシル ルチンを併用したもの
(試料B)を投与したIV群のそれは24mmと約37
%に低減している。As is clear from the results shown in Table 4, the ulcer index of the group V to which the pine extract (sample C) was administered was 35 m compared to the ulcer index of the control group I (the group to which distilled water was administered) of 65 mm.
m and about 54%, and that of group III to which a combination of pine extract and bamboo extract and plum extract was administered (sample A) was reduced to 26 mm and about 40%, and that α-glycosyl rutin was used in combination. The group IV to which the sample (Sample B) was administered was 24 mm and about 37 mm.
%.
【0077】このことからマツエキスはストレス性胃潰
瘍抑制効果を有するとともに、その効果は、タケエキス
およびウメエキスの併用により増強され、更に、α−グ
リコシル ルチンの併用によって増強されることが判明
した。From these results, it was found that the pine extract had an effect of suppressing stress-induced gastric ulcer, and the effect was enhanced by the combined use of bamboo extract and plum extract, and further enhanced by the combined use of α-glycosylrutin.
【0078】[0078]
【実験5】 マクロファージ活性化効果[Experiment 5] Macrophage activation effect
【0079】実験3の方法で調製した試料A、Bおよび
Cを、10%牛胎仔血清および10mM Hepes緩
衝液(pH7.4)含有RPMI 1640培地で、そ
れぞれ100倍に希釈したものをマクロファージ活性化
剤として用いた。Samples A, B, and C prepared by the method of Experiment 3 were diluted 100-fold with RPMI 1640 medium containing 10% fetal calf serum and 10 mM Hepes buffer (pH 7.4), and activated for macrophage. Used as an agent.
【0080】マクロファージ活性化効果は、常法に従っ
て、BALB/cマウスの腹腔からマクロファージを採
取し、96ウェル・プレートに播種して付着させ、これ
に前記の活性化剤それぞれをウェル当り0.1ml添加
し、37℃、5%炭酸ガス雰囲気下でインキューベー
し、5時間後に、写真撮影し、それぞれ、全マクロファ
ージ数に対する活性化して伸展したマクロファージ数の
割合を求めて、その活性化率(%)とし、その大小で判
定した。対照には、蒸留水を用いた。The macrophage activating effect was determined by collecting macrophages from the abdominal cavity of BALB / c mice according to a conventional method, disseminating the macrophages in a 96-well plate and allowing them to adhere thereto, and adding each of the activators described above in an amount of 0.1 ml / well. After addition, the mixture was incubated at 37 ° C. in a 5% carbon dioxide atmosphere, photographed 5 hours later, and the ratio of the number of activated and expanded macrophages to the total number of macrophages was determined. ), And the judgment was made based on the magnitude. Distilled water was used as a control.
【0081】結果は、表5に示す。The results are shown in Table 5.
【0082】[0082]
【表5】 [Table 5]
【0083】表5の結果から明らかなように、マツエキ
ス自体(試料C)でも、マクロファージ活性化効果が見
られるが、その効果は、タケエキスおよびウメエキスの
併用(試料A)により増強される。更に、α−グリコシ
ル ルチンの併用(試料B)によって、その効果は更に
増強されることが判明した。As is clear from the results in Table 5, the pine extract itself (sample C) also has a macrophage activating effect, but the effect is enhanced by the combined use of bamboo extract and plum extract (sample A). Furthermore, it was found that the effect was further enhanced by the combined use of α-glycosyl rutin (sample B).
【0084】[0084]
【実験6】 急性毒性[Experiment 6] Acute toxicity
【0085】7週齢のdd系マウスを使用して、実験3
の方法で調製した試料Aまたは試料Bの凍結乾燥品を経
口投与して急性毒性をテストしたところ、一匹当り、い
ずれも0.5gまで死亡例が見られず、これ以上の投与
は困難であった。したがって、これら試料の毒性は極め
て低い。Experiment 3 was performed using a 7-week-old dd mouse.
Acute toxicity was tested by orally administering the lyophilized product of Sample A or Sample B prepared in accordance with the method described above. As a result, no deaths were observed up to 0.5 g per animal , and further administration was difficult. there were. Therefore, the toxicity of these samples is extremely low.
【0086】以下、本発明の2〜3の実施例を述べる。Hereinafter, a few embodiments of the present invention will be described.
【0087】[0087]
【実施例1】 飲料[Example 1] Beverage
【0088】水に、下記の配合割合に従い、それぞれの
成分を溶解し、不溶物を除去し、精密濾過し、次いで1
00ml容ボトルに無菌充填、施栓して、マツエキス含
有飲料を製造した。In water, each component was dissolved in accordance with the following mixing ratio, insolubles were removed, and microfiltration was performed.
A pine extract-containing beverage was produced by aseptically filling and plugging a 00-ml bottle.
【0089】 配合物 固形分(%) マツエキス 0.05 タケエキス 0.3 ウメエキス 3.0 異性化糖 10.0 水Formulation Solid content (%) Pine extract 0.05 Bamboo extract 0.3 Plum extract 3.0 Isomerized sugar 10.0 Water
【0090】本品は、嗜好性の優れたマツエキス含有飲
料で、健康の維持、増進に、また、各種疾患の予防、治
療、回復促進に有利に利用できる。The product is a pine extract-containing beverage having excellent palatability and can be advantageously used for maintaining and promoting health, and for preventing, treating and promoting recovery from various diseases.
【0091】また、本品は、各種飲食物に配合して、そ
の風味改善、日持向上、品質安定などの目的を達成する
ことも有利に実施できる。The product can be advantageously mixed with various foods and drinks to achieve the objectives of improving flavor, improving shelf life, and stabilizing quality.
【0092】[0092]
【実施例2】 飲料Example 2 Beverage
【0093】下記の配合割合により、実施例1の場合と
同様に、マツエキス含有飲料を製造した。A pine extract-containing beverage was produced in the same manner as in Example 1 at the following compounding ratios.
【0094】 配合物 固形分(%) マツエキス 0.1 タケエキス 0.5 ウメエキス 2.0 クエン酸 0.5 L−アスコルビン酸 0.5 水飴 20.0 α−グリコシル ルチン 0.1 水Formulation Solid content (%) Pine extract 0.1 Bamboo extract 0.5 Plum extract 2.0 Citric acid 0.5 L-ascorbic acid 0.5 Syrup 20.0 α-glycosyl rutin 0.1 Water
【0095】本品は、嗜好性の優れたマツエキス含有飲
料で、実施例1の場合と同様に健康の維持、増進に、ま
た、養毛剤、更には、各種疾患の予防、治療、回復促進
に有利に利用できる。This product is a pine extract-containing beverage having excellent palatability, and is advantageous for maintaining and promoting health, as well as for hair restoration, and for preventing, treating and promoting recovery from various diseases as in Example 1. Available to
【0096】更に、本品は、各種飲食物に配合して、そ
の風味改善、日持向上、品質安定などの目的を達成する
ことも有利に実施できる。Further, the product can be advantageously blended with various foods and drinks to achieve the objectives of improving flavor, improving shelf life, and stabilizing quality.
【0097】[0097]
【実施3】 粉末品 ペースト状マツエキス1重量部にペースト状のタケエキ
ス3重量部およびペースト状ウメエキス7重量部を混捏
し、これにシクロデキストリン含有粉飴40重量部およ
び無水結晶マルトース20重量部を加えて混合し、つい
で40℃で1時間通風乾燥し、更に、無水結晶マルトー
ス20重量部を均一に混合し、これをラミネートアルミ
製包装容器に1グラムずつ充填し密封した。Example 3 Powdered product 3 parts by weight of paste-like bamboo extract and 7 parts by weight of pasty ume extract were kneaded with 1 part by weight of paste-like pine extract, and 40 parts by weight of cyclodextrin-containing powdered candy and 20 parts by weight of anhydrous crystalline maltose were added. Then, the mixture was air-dried at 40 ° C. for 1 hour, and further, 20 parts by weight of anhydrous crystalline maltose were mixed uniformly, and this was filled in a laminated aluminum packaging container by 1 gram and sealed.
【0098】本品は、水に溶解性良好で、嗜好性にも優
れ、健康食品、抗ウイルス剤、抗ストレス剤などとして
直接に経口摂取されるだけでなく、他の経口摂取物、例
えば、飲料、菓子、調味料、口中使用物、内服薬などの
配合材料として使用され、健康の維持増進、更には、各
種疾患の予防、治療、回復促進に有利に利用できる。The product has good solubility in water and excellent palatability, and is not only taken directly orally as a health food, an antiviral agent, an antistress agent, etc., but also used in other oral products, for example, It is used as a compounding material for beverages, confections, seasonings, oral products, oral medicines, etc., and can be advantageously used for maintaining and promoting health, and for preventing, treating and promoting recovery from various diseases.
【0099】[0099]
【実施例4】 錠剤Example 4 Tablet
【0100】L−アスコルビン酸1重量部に、実施例3
の方法で得たマツエキス含有経口摂取物粉末品10重量
部、コーンスターチ2.5重量部、無水結晶マルトース
粉末7.5重量およびα−グリコシル ルチン0.5重
量部を均一に混合した後、直径12mm、20R杆を用
いて、打錠し錠剤を得た。Example 1 was added to 1 part by weight of L-ascorbic acid.
After uniformly mixing 10 parts by weight of the pine extract-containing orally ingestible powder obtained by the above method, 2.5 parts by weight of corn starch, 7.5 parts by weight of anhydrous crystalline maltose powder, and 0.5 parts by weight of α-glycosyl rutin, the diameter was 12 mm. Tablets were obtained using a 20R rod.
【0101】本品は、マツエキス、タケエキス、ウメエ
キス本来の効果のみならず、L−アスコルビン酸、α−
グリコシル ルチンによる複合ビタミンの効果をも発揮
しうる嗜好性の優れた錠剤である。This product is not only effective for pine extract, bamboo extract and plum extract, but also for L-ascorbic acid, α-
It is a tablet with excellent palatability that can also exert the effect of multivitamin by glycosyl rutin.
【0102】本品は、健康の維持、増進、また、養毛
剤、更には、各種疾患の予防、治療、回復促進に有利に
利用できる。The product can be advantageously used for maintaining and promoting health, as well as for hair restoration, and also for preventing, treating and promoting recovery of various diseases.
【0103】[0103]
【実施例5】 チューインガムExample 5 Chewing gum
【0104】ガムベース3重量部を柔らかくなる程度に
加熱溶融し、これに実施例3の方法で得たマツエキス含
有経口摂取物粉末品7重量部および薬用人参エキス0.
1重量部を加え、これにステビア甘味料0.1重量部と
適量の着色料、着香料とを混合し、常法に従って、ロー
ルにより練り合わせ、成形、包装して製品を得た。3 parts by weight of the gum base were heated and melted to a degree to be soft, and 7 parts by weight of the pine extract-containing orally ingestible powder obtained by the method of Example 3 and ginseng extract 0.1 part.
One part by weight was added, and 0.1 part by weight of a stevia sweetener was mixed with an appropriate amount of a coloring agent and a flavoring agent, and kneaded with a roll according to a conventional method, followed by molding and packaging to obtain a product.
【0105】本品は、テクスチャー、風味とも良好なチ
ューインガムで、虫歯を起こしにくい。The product is a chewing gum having good texture and flavor and is less likely to cause tooth decay.
【0106】また、本品は、健康の維持、増進、更に
は、各種疾患の予防、治療、回復促進に有利に利用でき
る。The product can be advantageously used for maintaining and promoting health, and for preventing, treating and promoting recovery of various diseases.
【0107】[0107]
【実施例6】 グミキャンディー[Example 6] Gummy candy
【0108】還元麦芽糖水飴(株式会社林原商事販売、
登録商標マビット)90重量部に実施例3の方法で得た
マツエキス含有経口摂取物60重量部を加熱混和し、こ
れにゼラチン13重量部を水18重量部に溶解したもの
および適量の着色料、香料を混合し、成形、包装してグ
ミキャンディーを得た。Reduced maltose syrup (Hayashibara Shoji Co., Ltd.,
(Registered trademark: Mavit) 60 parts by weight of the pine extract-containing oral ingestion obtained by the method of Example 3 was mixed with 90 parts by weight under heating, and 13 parts by weight of gelatin was dissolved in 18 parts by weight of water. The fragrance was mixed, molded and packaged to obtain a gummy candy.
【0109】本品は、テクスチャー、風味とも良好なグ
ミキャンディーである。This product is a gummy candy with good texture and flavor.
【0110】また、本品は、健康の維持、増進、更には
各種疾患の予防、治療、回復促進などに有利に利用でき
る。The product can be advantageously used for maintaining and promoting health, preventing, treating and promoting recovery of various diseases.
【0111】[0111]
【実施例7】 バターケーキ[Example 7] Butter cake
【0112】無塩バター50重量部、ショートニング5
0重量部、蜂蜜50重量部および砂糖130重量部をよ
く混合し、これに全卵150重量部を加えて撹拌し、次
いで小麦粉135重量部、牛乳75重量部、重曹4重量
部およびバニラ適量を混合し、常法に従って、型に入
れ、焼き上げ、室温に冷却した。この表面に、実施例1
の方法で得た飲料80重量部、梅リキュール20重量部
およびコニャック20重量部を混合して得たシロップを
刷毛で塗り、製品を得た。50 parts by weight of unsalted butter, shortening 5
0 parts by weight, 50 parts by weight of honey and 130 parts by weight of sugar are mixed well, 150 parts by weight of whole eggs are added and stirred, and then 135 parts by weight of flour, 75 parts by weight of milk, 4 parts by weight of baking soda and an appropriate amount of vanilla are added. The mixture was mixed, placed in a mold, baked and cooled to room temperature according to a conventional method. On this surface, Example 1
A syrup obtained by mixing 80 parts by weight of the beverage obtained by the above method, 20 parts by weight of plum liqueur and 20 parts by weight of cognac was applied with a brush to obtain a product.
【0113】本品は、風味良好なバターケーキである。
また、本品は、健康の維持、増進、更には各種疾患の予
防、治療、回復促進などに有利に利用できる。The product is a good-tasting butter cake.
The product can be advantageously used for maintaining and promoting health, and for preventing, treating and promoting recovery of various diseases.
【0114】[0114]
【実施例8】 アイスクリームExample 8 Ice cream
【0115】牛乳2,000重量部を約60℃に加温し
つつ、これに、卵黄200重量部、全卵50重量部、果
糖420重量部、水飴30重量部、生クリーム200重
量部、無糖練乳20重量部、実施例2の方法で得た飲料
300重量部およびゼラチン粉末1重量部を撹拌混合
し、次いで、75℃に15分間保って殺菌し、更に、冷
却しつつ、梅リキュール20重量部を撹拌混合し、容器
に入れ、凍結して製品を得た。While heating 2,000 parts by weight of milk to about 60 ° C., 200 parts by weight of egg yolk, 50 parts by weight of whole egg, 420 parts by weight of fructose, 30 parts by weight of starch syrup, 200 parts by weight of fresh cream, 20 parts by weight of condensed milk, 300 parts by weight of the beverage obtained by the method of Example 2 and 1 part by weight of gelatin powder were mixed by stirring, and then sterilized at 75 ° C. for 15 minutes. The parts by weight were mixed with stirring, placed in a container, and frozen to obtain a product.
【0116】本品は、濃厚、佳良な風味を持つアイスク
リームである。また、本品は、健康の維持、増進、更に
は各種疾患の予防、治療、回復促進などに有利に利用で
きる。The product is an ice cream having a rich and good flavor. The product can be advantageously used for maintaining and promoting health, and for preventing, treating and promoting recovery of various diseases.
【0117】[0117]
【発明の効果】本文で述べたごとく、本発明は、従来の
マツエキスの持つ激しいマツヤニ臭、強い苦味、渋味の
欠点が、生薬として有効なタケエキスおよびウメエキス
を特定割合に含有せしめることにより解消され、マツエ
キスの嗜好性を向上できるだけでなく、同時にマツエキ
スの効能、効果を著しく高めることとなったことから、
これを含有せしめた本発明のマツエキスを含有する経口
摂取物は、健康飲食物、養毛剤、抗感受性疾患剤などと
して有利に利用できる。As described in the text, the present invention overcomes the disadvantages of the conventional pine extract, such as the intense pine odor, strong bitterness, and astringency, by including bamboo extract and plum extract, which are effective as crude drugs, in specific ratios. In addition to improving the palatability of pine extract, at the same time, the efficacy and effect of pine extract were significantly increased,
An oral ingestion containing the pine extract of the present invention containing the same can be advantageously used as a health food / drink, a hair restorer, an anti-sensitive disease agent and the like.
フロントページの続き (51)Int.Cl.7 識別記号 FI A61P 31/12 A61P 31/12 35/00 35/00 (58)調査した分野(Int.Cl.7,DB名) A61K 35/78 A23L 1/29 A23L 1/30 A61K 7/06 BIOSIS(DIALOG) CA(STN)Continuation of the front page (51) Int.Cl. 7 identification code FI A61P 31/12 A61P 31/12 35/00 35/00 (58) Fields investigated (Int.Cl. 7 , DB name) A61K 35/78 A23L 1/29 A23L 1/30 A61K 7/06 BIOSIS (DIALOG) CA (STN)
Claims (6)
マツエキスに対して、タケエキスおよびウメエキスを固
形物当り、それぞれ0.1乃至20倍量および1乃至2
00倍量の範囲で含有せしめることを特徴とするマツエ
キスの嗜好性改善方法。1. To improve the palatability of pine extract,
Bamboo extract and plum extract are 0.1 to 20 times and 1 to 2 times the amount of pine extract per solid, respectively.
A method for improving the palatability of pine extract, characterized in that the pine extract is contained in a range of 00 times.
%以上含有せしめることを特徴とする請求項1記載の嗜
好性改善方法。2. A pine extract containing 0.01 w / w of solids per solid
%. The method for improving palatability according to claim 1, wherein the content is not less than 0.1%.
%以上含有せしめるとともに、マツエキスに対して、タ
ケエキスおよびウメエキスを、固形物当り、それぞれ
0.1乃至20倍量および1乃至200倍量の範囲で含
有せしめたマツエキス含有経口摂取物。3. A pine extract having a weight of 0.01 w / w per solid.
% Pine extract, and a bamboo extract and a plum extract are contained in an amount of 0.1 to 20 times and 1 to 200 times the solid content of the pine extract, respectively.
%以上含有せしめるとともに、マツエキスに対して、タ
ケエキス、ウメエキスおよびα−グリコシルルチンを固
形物当り、それぞれ0.1乃至20倍量、1乃至200
倍量および0.1乃至10倍量含有せしめたマツエキス
含有経口摂取物。4. A pine extract containing 0.01 w / w of solids per solid
% Or more, and bamboo extract, plum extract and α-glycosylrutin are 0.1 to 20 times the solid content of the pine extract, 1 to 200 times, respectively.
A pine extract-containing oral ingestion containing twice and 0.1 to 10 times the amount.
物、養毛剤または抗感受性疾患剤であることを特徴とす
る請求項3または請求項4記載のマツエキス含有経口摂
取物。5. The pine extract-containing oral ingestion according to claim 3, wherein the oral ingestion is a health food and drink, an oral use, a hair restorer or an anti-sensitivity disease agent.
経疾患剤であることを特微とする請求項5記戦のマツエ
キス含有経口摂取物。6. The pine extract-containing oral ingestion according to claim 5, wherein the anti-susceptibility agent is an anti-infective agent or an anti-neurological agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11204793A JP3203572B2 (en) | 1992-04-02 | 1993-04-02 | Method for improving palatability of pine extract and oral intake obtained by this method |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4-126605 | 1992-04-02 | ||
| JP12660592 | 1992-04-02 | ||
| JP11204793A JP3203572B2 (en) | 1992-04-02 | 1993-04-02 | Method for improving palatability of pine extract and oral intake obtained by this method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH069419A JPH069419A (en) | 1994-01-18 |
| JP3203572B2 true JP3203572B2 (en) | 2001-08-27 |
Family
ID=26451296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11204793A Expired - Fee Related JP3203572B2 (en) | 1992-04-02 | 1993-04-02 | Method for improving palatability of pine extract and oral intake obtained by this method |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3203572B2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030087385A (en) * | 2002-05-08 | 2003-11-14 | 안순정 | Hair loss prevention, hair growth, hair growth promoter |
| JPWO2003105878A1 (en) * | 2002-06-13 | 2005-10-13 | 株式会社鳳凰堂 | Antibacterial agent and antibacterial composition |
| JP4562365B2 (en) * | 2003-09-19 | 2010-10-13 | 株式会社ノエビア | Health promotion composition |
| JP2008161077A (en) * | 2006-12-27 | 2008-07-17 | Spangle:Kk | Functional food with blood flowability improving effect |
| JP5537893B2 (en) * | 2009-10-14 | 2014-07-02 | 株式会社ゼックフィールド | Anti-influenza virus type A |
| WO2024225320A1 (en) * | 2023-04-28 | 2024-10-31 | Med R&D株式会社 | Vitality improving agent, composition for improving vitality, and food composition for improving vitality |
-
1993
- 1993-04-02 JP JP11204793A patent/JP3203572B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH069419A (en) | 1994-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100268401B1 (en) | Method for improving the taste of pine extract, and orally administrable product obtained thereby | |
| US7229658B1 (en) | Compositions containing sucralose and application thereof | |
| KR101007790B1 (en) | Associates of trehalose or maltitol and metal ion compounds | |
| JP3843009B2 (en) | Oral material with improved taste, method for improving taste of oral material and method for using enzyme-treated ginkgo biloba extract | |
| JPWO2004060077A1 (en) | Method for reducing unpleasant taste and / or unpleasant odor | |
| US20120121734A1 (en) | Compositions containing sucralose and application thereof | |
| JPWO2000024273A1 (en) | Sucralose-containing compositions and their applications | |
| TWI361668B (en) | ||
| JP3381010B2 (en) | Fermented product containing propolis extract, production method and use thereof | |
| JPH07278012A (en) | Metabolic promoter and food containing the same blended | |
| TW542829B (en) | Acyl derivatives of glycosyl-L-ascorbic acid | |
| JP4135816B2 (en) | Propolis extract with improved water solubility | |
| JP3203572B2 (en) | Method for improving palatability of pine extract and oral intake obtained by this method | |
| JP7500927B2 (en) | Protein masking agent | |
| JP2010265215A (en) | Methioninase inhibitor | |
| US12274781B2 (en) | Use of enzyme-modified isoquercitrin | |
| JP2006316053A (en) | Cytotoxic inhibitors and their uses | |
| KR102590017B1 (en) | Composition for improving oral condition | |
| JP2009046420A (en) | Immunostimulant and food and drink containing the same | |
| JP7311878B2 (en) | Cytotoxicity inhibitor and HO-1 gene expression enhancer | |
| WO1999043219A1 (en) | Ginkgo leaf extract compositions and foods containing the same | |
| TW470749B (en) | Propolis extract with improved water-solubility | |
| JPH0523153A (en) | Food and drink or oral products containing coix extract | |
| RU2317299C2 (en) | Associate containing trehalose and calcium chloride as crystalline monohydrate or anhydrous crystal | |
| JP2024056412A (en) | Sleep aids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070629 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080629 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090629 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090629 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100629 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110629 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120629 Year of fee payment: 11 |
|
| LAPS | Cancellation because of no payment of annual fees |